SCHEMBL20005701

SCHEMBL20005701

C=C1SC(=S)N(C(C)c2ccccc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.55
MAPK1 P28482 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
SAE1 Q9UBE0 1/20 0.38
UBA2 Q9UBT2 1/20 0.38
BCL2 P10415 2/20 0.38
BCL2L2 Q92843 2/20 0.38
CYP2D6 P10635 1/20 0.37
POLB P06746 3/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
FPR1 P21462 1/20 0.35
PSMD14 O00487 1/20 0.35
NSD2 O96028 1/20 0.35
ALPL P05186 1/20 0.35
MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475117 0.79 MAPT (0.58) MAPTMAPK1L3MBTL1ALDH1A1SAE1
SCHEMBL29393294 0.69 LMNA (0.58) ALDH1A1HPGDCYP2D6POLBLMNA
SCHEMBL6925572 0.69 LMNA (0.58) ALDH1A1HPGDCYP2D6POLBLMNA
SCHEMBL607042 0.69 LMNA (0.58) ALDH1A1HPGDCYP2D6POLBLMNA
SCHEMBL10134069 0.68 MEN1 (0.51) MAPTMAPK1L3MBTL1ALDH1A1POLB
SCHEMBL11117773 0.68 MAPT (0.42) MAPTMAPK1L3MBTL1ALDH1A1HPGD
SCHEMBL7557936 0.67 ALDH1A1 (0.47) MAPTMAPK1L3MBTL1ALDH1A1HPGD
SCHEMBL3817361 0.66 ALDH1A1 (0.50) MAPTMAPK1L3MBTL1ALDH1A1HPGD
SCHEMBL1795649 0.66 ALDH1A1 (0.50) MAPTMAPK1L3MBTL1ALDH1A1HPGD
SCHEMBL717117 0.66 ALDH1A1 (0.50) MAPTMAPK1L3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MAPT 3938/4885MAPK1 2158/4885L3MBTL1 805/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MAPT 3938/4885MAPK1 2158/4885L3MBTL1 805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.